Akero Therapeutics Stock Target Price and Analyst Consensus
AKRO Stock | USD 22.99 0.03 0.13% |
The current analyst and expert consensus on Akero Therapeutics is Strong Buy, with 5 strong buy opinions. The current projected Akero Therapeutics target price consensus is 43.56 with 9 analyst opinions. The most common way Akero Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Akero Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Akero Therapeutics. We strongly encourage you to use your own analysis of Akero Therapeutics to validate this buy or sell advice. Akero Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Akero Therapeutics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Akero Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Akero Stock, please use our How to Invest in Akero Therapeutics guide.
Lowest Forecast 39.64 | Highest Forecast 48.35 | Target Price 43.56 |
Akero |
It's important to approach Akero Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Akero Therapeutics Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Akero target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Akero Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
9 | Strong Buy |
Most Akero analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Akero stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Akero Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAkero Therapeutics Target Price Projection
Akero Therapeutics' current and average target prices are 22.99 and 43.56, respectively. The current price of Akero Therapeutics is the price at which Akero Therapeutics is currently trading. On the other hand, Akero Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Akero Therapeutics Market Quote on 11th of June 2024
Target Price
Analyst Consensus On Akero Therapeutics Target Price
Akero Therapeutics Analyst Ratings
Akero Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Akero Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Akero Therapeutics' financials, market performance, and future outlook by experienced professionals. Akero Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Akero Therapeutics price targets
Akero Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Akero Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Akero Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Akero Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Akero Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Akero Therapeutics is a key component of Akero Therapeutics valuation and have some predictive power on the future returns of a Akero Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akero Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Macroaxis Index Invested over 90 shares | ||
Additional Information and Resources on Investing in Akero Stock
When determining whether Akero Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akero Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akero Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akero Therapeutics Stock:Check out Macroaxis Advice on Akero Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Akero Stock, please use our How to Invest in Akero Therapeutics guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
The data published in Akero Therapeutics' official financial statements typically reflect Akero Therapeutics' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Akero Therapeutics' quantitative information. For example, before you start analyzing numbers published by Akero accountants, it’s essential to understand Akero Therapeutics' liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.